Security key
00973N102
Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ)
CUSIP: 00973N102
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 40,766,012
- Total 13F value
- $24,082,620
- Share change
- +12,001,364
- Put/Call ratio
- 7.8%
- SEC-reported price per share
- $0.59
- Number of holders
- 114
- Value change
- +$6,776,273
- Number of buys
- 55
- Number of sells
- 35
- Shares outstanding
- 53,401,149
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
114
Top holders
10
AKTSQ full security history
Ownership snapshot
Full 13F holder table
Aktis Oncology, Inc. SEC filings
Aktis Oncology, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AKTSQ - Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GOLDMAN SACHS GROUP INC
Disclosed value leader
GOLDMAN SACHS GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $14,205,881
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
GOLDMAN SACHS GROUP INC has the largest disclosed position value at $14.21M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GOLDMAN SACHS GROUP INC's linked filing trail.
Disclosed position value
Top 5
GOLDMAN SACHS GROUP INC
$14.21M
BlackRock Finance, Inc.
$4.18M
VANGUARD GROUP INC
$3.02M
SILVERBACK ASSET MANAGEMENT LLC
$2.8M
Senvest Management, LLC
$1.83M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
denominator unverified
|
$14,205,881
33,377 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$4,180,406
5,012,476 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$3,024,754
3,626,804 shares
|
— | 31 Dec 2023 |
| SILVERBACK ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$2,799,302
3,353,351 shares
|
— | 31 Dec 2023 |
| Senvest Management, LLC |
13F
Company
|
—
denominator unverified
|
$1,831,945
2,196,577 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$1,235,201
1,480,895 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
114
Shares
40,766,012
Rows available
114
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
114
Q1 2024 holders
114
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|